Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dissecting eIF4E action in tumorigenesis.

Hans-Guido Wendel1, Ricardo L A Silva, Abba Malina

  • 1Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. wendelh@mskcc.org

Genes & Development
|December 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting eIF4A-dependent translation in genetically complex sarcoma.

JCI insight·2026
Same author

eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma.

The Journal of experimental medicine·2024
Same author

eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer.

bioRxiv : the preprint server for biology·2024
Same author

Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma.

Blood cancer journal·2024
Same author

FIRRM cooperates with FIGNL1 to promote RAD51 disassembly during DNA repair.

Science advances·2023
Same journal

Corrigendum: Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice.

Genes & development·2026
Same journal

A new perspective on ATR's role in translesion synthesis.

Genes & development·2026
Same journal

Mechanisms coordinating exit from the stem cell state in mammals.

Genes & development·2026
Same journal

Evolutionarily conserved spliceosome-exosome pathway in nuclear mRNA surveillance.

Genes & development·2026
Same journal

CDK1 and CEP97 cooperatively control centriole length to orchestrate ciliogenesis and developmental patterning.

Genes & development·2026
Same journal

Coupling of translesion synthesis with the replisome stabilized at stalled replication forks by ATR.

Genes & development·2026
See all related articles

The translation initiation factor eIF4E drives cancer by activating translation and suppressing apoptosis. Targeting this oncogenic activity, particularly through its kinase MNK1, offers a potential therapeutic strategy for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Genetically engineered mouse models are crucial for cancer gene research and therapeutic target validation.
  • The translation initiation factor eIF4E has been identified as a potent oncogene in vivo.

Purpose of the Study:

  • To investigate the correlation between eIF4E's oncogenic activity and its translational control functions.
  • To explore the role of MNK1, a kinase for eIF4E, in tumorigenesis.
  • To identify therapeutic targets within the eIF4E-mediated translational control pathway.

Main Methods:

  • Utilized a previously established mouse lymphoma model.
  • Assessed the phosphorylation of eIF4E on Ser 209 and its correlation with oncogenic activity.
  • Investigated the effects of constitutively active and dominant-negative MNK1 mutants on tumor cell proliferation.

Related Experiment Videos

  • Examined the role of the anti-apoptotic protein Mcl-1 as a downstream target.

    • Main Results:

    • The oncogenic activity of eIF4E in vivo is linked to its translation-activating function and Ser 209 phosphorylation.
    • Activated MNK1 promotes tumorigenesis similarly to eIF4E.
    • A dominant-negative MNK1 mutant suppressed tumor cell proliferation.
    • Phosphorylated eIF4E and MNK1 contribute to tumor formation by suppressing apoptosis, partly through regulating Mcl-1.

    Conclusions:

    • eIF4E contributes to tumorigenesis by enhancing translation and suppressing apoptosis.
    • MNK1 plays a significant role in eIF4E-driven tumorigenesis.
    • Translational control mediated by eIF4E and MNK1 represents a potential therapeutic intervention point for cancer.